From plant to cancer drug: lessons learned from the discovery of taxol
Natural Product Reports · 2023 · 40 (7) · 1153-1157
DOI: 10.1039/d3np00017f ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Natural Product Reports, 2023. Verfasst von Nadja B Cech und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of North Carolina Greensboro, USA. nadja_cech@uncg.edu. Hauptthemen laut MEDLINE: Antineoplastic Agents, Phytogenic, Biological Products, Neoplasms. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
This Viewpoint describes events during the 1960s and 1970s that led to the discovery of taxol, which remains one of the most effective treatments for breast and ovarian cancer. We highlight lessons relevant to natural products drug discovery today.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of North Carolina Greensboro, USA. nadja_cech@uncg.edu.
ORCID-Profile: Nadja B Cech, Nicholas H Oberlies
Förderung
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
Cech, N. B., & Oberlies, N. H. (2023). From plant to cancer drug: lessons learned from the discovery of taxol. Natural Product Reports, 40(7), 1153-1157. https://doi.org/10.1039/d3np00017f
Vancouver
Cech NB, Oberlies NH. From plant to cancer drug: lessons learned from the discovery of taxol. Natural Product Reports. 2023;40(7):1153-1157. doi:10.1039/d3np00017f
BibTeX
@article{Cech2023,
author = {Cech, Nadja B and Oberlies, Nicholas H},
title = {From plant to cancer drug: lessons learned from the discovery of taxol},
journal = {Natural Product Reports},
year = {2023},
volume = {40},
number = {7},
pages = {1153--1157},
doi = {10.1039/d3np00017f}
}
EUVIMED